Oncternal Therapeutics, Inc.
ONCTDelisted Mar 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001260990
Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Oncternal Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 67 | 85 | +18 |
| Shares | 9.90M | 13.7M | +3.82M (+38.6%) |
| Value | $82.5M | $65.2M | −$17.3M (−21.0%) |
New holders (27)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (9)
Institutions that held Oncternal Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sio Capital Management, LLC | 323,333 | $2.69M |
| ExodusPoint Capital Management, LP | 94,561 | $787.0K |
| Susquehanna Fundamental Investments, LLC | 42,702 | $355.0K |
| Total Clarity Wealth Management, Inc. | 31,065 | $258.0K |
| HRT Financial LP | 28,732 | $239.0K |
| Spire Wealth Management | 6,500 | $49.0K |
| Valeo Financial Advisors, LLC | 3,500 | $29.0K |
| Brown Brothers Harriman & Co | 2 | $0 |
| FMR LLC | 1 | $0 |